Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 16 | 2024 | 233 | 7.110 |
Why?
|
| Atrial Fibrillation | 27 | 2024 | 623 | 6.620 |
Why?
|
| Cardiac Resynchronization Therapy | 7 | 2023 | 28 | 3.950 |
Why?
|
| Tachycardia, Ventricular | 6 | 2024 | 196 | 2.430 |
Why?
|
| Pulmonary Veins | 3 | 2023 | 163 | 2.180 |
Why?
|
| Heart Failure | 12 | 2024 | 2125 | 2.080 |
Why?
|
| Heart Atria | 8 | 2023 | 310 | 1.750 |
Why?
|
| Esophagus | 3 | 2021 | 212 | 1.750 |
Why?
|
| Heart Conduction System | 6 | 2024 | 146 | 1.440 |
Why?
|
| Electrocardiography | 11 | 2024 | 964 | 1.440 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 3479 | 1.350 |
Why?
|
| Pacemaker, Artificial | 3 | 2024 | 170 | 1.340 |
Why?
|
| Cardiac Conduction System Disease | 2 | 2024 | 7 | 1.160 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2019 | 218 | 1.150 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2023 | 457 | 1.120 |
Why?
|
| Gadolinium | 5 | 2021 | 103 | 1.090 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 192 | 1.050 |
Why?
|
| Equipment Failure | 2 | 2015 | 123 | 0.910 |
Why?
|
| Cryosurgery | 1 | 2022 | 47 | 0.800 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 353 | 0.770 |
Why?
|
| Contrast Media | 4 | 2021 | 469 | 0.760 |
Why?
|
| Bundle-Branch Block | 3 | 2023 | 35 | 0.740 |
Why?
|
| Heart Rate | 3 | 2022 | 584 | 0.740 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 86 | 0.720 |
Why?
|
| Burns | 1 | 2021 | 77 | 0.720 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 6 | 2009 | 232 | 0.680 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 23 | 0.670 |
Why?
|
| Humans | 51 | 2024 | 122853 | 0.670 |
Why?
|
| Treatment Outcome | 18 | 2024 | 12070 | 0.670 |
Why?
|
| Esophageal Diseases | 1 | 2018 | 35 | 0.610 |
Why?
|
| Meglumine | 1 | 2018 | 15 | 0.610 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2009 | 196 | 0.600 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2021 | 246 | 0.600 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 106 | 0.580 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 481 | 0.580 |
Why?
|
| Stroke | 2 | 2023 | 957 | 0.560 |
Why?
|
| Calcium | 4 | 2009 | 1097 | 0.530 |
Why?
|
| Recurrence | 4 | 2024 | 1419 | 0.530 |
Why?
|
| Fibrosis | 6 | 2023 | 429 | 0.530 |
Why?
|
| Myocardium | 2 | 2019 | 983 | 0.510 |
Why?
|
| Device Removal | 2 | 2016 | 223 | 0.510 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1022 | 0.500 |
Why?
|
| Aged | 18 | 2024 | 18917 | 0.500 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 611 | 0.500 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2015 | 13 | 0.490 |
Why?
|
| Heart | 1 | 2019 | 725 | 0.470 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 363 | 0.470 |
Why?
|
| Baseball | 1 | 2013 | 6 | 0.450 |
Why?
|
| Sinoatrial Node | 2 | 2024 | 24 | 0.440 |
Why?
|
| Medical Errors | 1 | 2015 | 155 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1246 | 0.400 |
Why?
|
| Male | 23 | 2024 | 59866 | 0.390 |
Why?
|
| Kidney Failure, Chronic | 2 | 2022 | 866 | 0.380 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2009 | 168 | 0.370 |
Why?
|
| Middle Aged | 16 | 2024 | 25798 | 0.370 |
Why?
|
| Intensive Care Units | 1 | 2014 | 483 | 0.350 |
Why?
|
| Stroke Volume | 4 | 2023 | 448 | 0.330 |
Why?
|
| Retrospective Studies | 9 | 2024 | 15927 | 0.330 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 6325 | 0.320 |
Why?
|
| Biomarkers | 1 | 2018 | 2947 | 0.320 |
Why?
|
| Female | 18 | 2024 | 65278 | 0.310 |
Why?
|
| Ventricular Function, Left | 4 | 2023 | 500 | 0.300 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2024 | 112 | 0.290 |
Why?
|
| Renal Dialysis | 1 | 2014 | 842 | 0.280 |
Why?
|
| Cardiology | 2 | 2022 | 472 | 0.270 |
Why?
|
| Malignant Hyperthermia | 1 | 2005 | 19 | 0.260 |
Why?
|
| Hot Temperature | 1 | 2005 | 136 | 0.250 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2004 | 20 | 0.240 |
Why?
|
| Atrial Appendage | 2 | 2015 | 42 | 0.220 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2023 | 60 | 0.220 |
Why?
|
| Income | 1 | 2024 | 133 | 0.220 |
Why?
|
| Sick Sinus Syndrome | 1 | 2022 | 12 | 0.210 |
Why?
|
| Cardiac Electrophysiology | 1 | 2022 | 10 | 0.210 |
Why?
|
| Anesthesia | 1 | 2005 | 209 | 0.210 |
Why?
|
| Ecosystem | 1 | 2022 | 76 | 0.200 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 5017 | 0.200 |
Why?
|
| Pericardial Effusion | 1 | 2022 | 64 | 0.190 |
Why?
|
| Time Factors | 3 | 2024 | 6202 | 0.190 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.190 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 1006 | 0.190 |
Why?
|
| Electronics | 1 | 2021 | 43 | 0.190 |
Why?
|
| Cardiovascular System | 1 | 2022 | 99 | 0.180 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 997 | 0.180 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 112 | 0.180 |
Why?
|
| Equipment Design | 3 | 2022 | 598 | 0.170 |
Why?
|
| Esophagoscopy | 1 | 2021 | 158 | 0.170 |
Why?
|
| Action Potentials | 2 | 2021 | 499 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 366 | 0.170 |
Why?
|
| Mutation | 4 | 2024 | 5794 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2021 | 149 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 667 | 0.160 |
Why?
|
| Hospitalization | 2 | 2024 | 1731 | 0.160 |
Why?
|
| Sorting Nexins | 1 | 2018 | 10 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2018 | 37 | 0.160 |
Why?
|
| Syndrome | 1 | 2021 | 1123 | 0.160 |
Why?
|
| Oxides | 1 | 2018 | 15 | 0.150 |
Why?
|
| Methylamines | 1 | 2018 | 17 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1881 | 0.150 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 89 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2008 | 66 | 0.150 |
Why?
|
| Ischemic Attack, Transient | 1 | 2017 | 55 | 0.140 |
Why?
|
| Operative Time | 1 | 2018 | 160 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 370 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 433 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 146 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 2827 | 0.140 |
Why?
|
| Cicatrix | 1 | 2018 | 125 | 0.140 |
Why?
|
| Suture Techniques | 2 | 2015 | 199 | 0.130 |
Why?
|
| Consensus | 1 | 2019 | 606 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2814 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 156 | 0.120 |
Why?
|
| Compassionate Use Trials | 1 | 2015 | 14 | 0.120 |
Why?
|
| Pericardium | 1 | 2015 | 82 | 0.120 |
Why?
|
| Inflammation | 1 | 2021 | 1400 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1634 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 233 | 0.110 |
Why?
|
| Risk Factors | 4 | 2024 | 9928 | 0.110 |
Why?
|
| Animals | 6 | 2024 | 33923 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2094 | 0.100 |
Why?
|
| Incidence | 2 | 2017 | 3033 | 0.090 |
Why?
|
| Obesity | 1 | 2021 | 2089 | 0.090 |
Why?
|
| Inpatients | 2 | 2024 | 490 | 0.090 |
Why?
|
| Goats | 1 | 2009 | 55 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.080 |
Why?
|
| Utah | 2 | 2020 | 45 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 1834 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 1101 | 0.080 |
Why?
|
| Caffeine | 2 | 2006 | 69 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2013 | 585 | 0.070 |
Why?
|
| Mice | 5 | 2021 | 17647 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 58 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2443 | 0.070 |
Why?
|
| Young Adult | 2 | 2024 | 8826 | 0.070 |
Why?
|
| United States | 4 | 2024 | 10538 | 0.070 |
Why?
|
| Adult | 4 | 2024 | 28926 | 0.070 |
Why?
|
| Peptides | 1 | 2009 | 799 | 0.060 |
Why?
|
| Isoflurane | 1 | 2005 | 45 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2009 | 1617 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2005 | 186 | 0.060 |
Why?
|
| Comorbidity | 2 | 2024 | 1490 | 0.060 |
Why?
|
| Anesthetics | 1 | 2005 | 81 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2004 | 17 | 0.060 |
Why?
|
| Electric Countershock | 1 | 2024 | 67 | 0.060 |
Why?
|
| Glucosides | 1 | 2024 | 44 | 0.060 |
Why?
|
| Smartphone | 1 | 2023 | 36 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2023 | 51 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 65 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 4308 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 618 | 0.050 |
Why?
|
| Italy | 1 | 2022 | 111 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2024 | 265 | 0.050 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.050 |
Why?
|
| India | 1 | 2022 | 218 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 17 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 36 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 180 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 1738 | 0.040 |
Why?
|
| Valine | 1 | 2020 | 106 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2021 | 241 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 336 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 932 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 397 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1000 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 287 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 163 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 754 | 0.040 |
Why?
|
| Cause of Death | 1 | 2017 | 455 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 37 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 3083 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 995 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 134 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3245 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 1996 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 193 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 5996 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3782 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 77 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 1998 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 113 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4392 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 241 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4673 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 1918 | 0.020 |
Why?
|
| Tetracaine | 1 | 2008 | 9 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4498 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 19037 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 124 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 138 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 174 | 0.020 |
Why?
|